The
natural product ouabagenin is a complex cardiotonic steroid
with a highly oxygenated skeleton. This full account describes the
development of a concise synthesis of ouabagenin, including the evolution
of synthetic strategy to access hydroxylation at the C19 position
of a steroid skeleton. In addition, approaches to install the requisite
butenolide moiety at the C17 position are discussed. Lastly, methodology
developed in this synthesis has been applied in the generation of
novel analogues of corticosteroid drugs bearing a hydroxyl group at
the C19 position.
The diterpenoid ester
ingenol mebutate (IngMeb) is the active ingredient
in the topical drug Picato, a first-in-class treatment for the precancerous
skin condition actinic keratosis. IngMeb is proposed to exert its
therapeutic effects through a dual mode of action involving (i) induction
of cell death that is associated with mitochondrial dysfunction followed
by (ii) stimulation of a local inflammatory response, at least partially
driven by protein kinase C (PKC) activation. Although this therapeutic
model has been well characterized, the complete set of molecular targets
responsible for mediating IngMeb activity remains ill-defined. Here,
we have synthesized a photoreactive, clickable analogue of IngMeb
and used this probe in quantitative proteomic experiments to map several
protein targets of IngMeb in human cancer cell lines and primary human
keratinocytes. Prominent among these targets was the mitochondrial
carnitine-acylcarnitine translocase SLC25A20, which we show is inhibited
in cells by IngMeb and the more stable analogue ingenol disoxate (IngDsx),
but not by the canonical PKC agonist 12-O-tetradecanoylphorbol-13-acetate
(TPA). SLC25A20 blockade by IngMeb and IngDsx leads to a buildup of
cellular acylcarnitines and blockade of fatty acid oxidation (FAO),
pointing to a possible mechanism for IngMeb-mediated perturbations
in mitochondrial function.
The calcipotriol/betamethasone dipropionate fixed-combination gel is widely used for topical treatment of psoriasis vulgaris. It has been hypothesized that calcipotriol counteracts glucocorticoid-induced skin atrophy which is associated with changes in the extracellular matrix (ECM). To elucidate the combined effects of calcipotriol and betamethasone on key ECM components, a comparative study to the respective mono-treatments was carried out. The effect on collagen I synthesis, matrix metalloproteinase (MMP) secretion, and hyaluronic acid (HA) production was investigated in primary human fibroblast and keratinocyte cultures as well as in a human skin explant model. We show that calcipotriol counteracts betamethasone-induced suppression of collagen I synthesis. Similarly, calcipotriol and betamethasone have opposing effects on MMP expression in both fibroblasts and keratinocytes. Moreover, calcipotriol is able to restore betamethasone-impaired HA synthesis in keratinocytes and prevent betamethasone-induced epidermal thinning in minipigs upon treatment with the calcipotriol/betamethasone gel. In summary, our results show for the first time in primary human skin cultures that calcipotriol reduces early signs of betamethasone-induced skin atrophy by modulation of key ECM components. These results indicate that the calcipotriol component of the fixed-combination gel counteracts the atrophogenic effects of betamethasone on the skin.Electronic supplementary materialThe online version of this article (doi:10.1007/s00403-014-1485-3) contains supplementary material, which is available to authorized users.
Ingenol derivatives with varying degrees of oxidation were prepared by two‐phase terpene synthesis. This strategy has allowed access to analogues that cannot be prepared by semisynthesis from natural ingenol. Complex ingenanes resulting from divergent C—H oxidation of a common intermediate were found to interact with protein kinase C in a manner that correlates well with the oxidation state of the ingenane core. Even though previous work on ingenanes has suggested a strong correlation between potential to activate PKCδ and induction of neutrophil oxidative burst, the current study shows that the potential to activate PKCβII is of key importance while interaction with PKCδ is dispensable. Thus, key modifications of the ingenane core allowed PKC isoform selectivity wherein PKCδ‐driven activation of keratinocytes is strongly reduced or even absent while PKCβII‐driven activation of neutrophils is retained.
Ingenol derivatives with varying degrees of oxidation were prepared by two-phase terpene synthesis.T his strategy has allowed access to analogues that cannot be prepared by semisynthesis from natural ingenol. Complex ingenanes resulting from divergent C À Ho xidation of ac ommon intermediate were found to interact with protein kinase Ci nam anner that correlates well with the oxidation state of the ingenane core
Thapsigargin (3) is a potent inhibitor of the SERCA-pump protein, with potential for application in a variety of medicinal areas. The efficient and scalable syntheses of thapsigargin (3) and nortrilobolide (2) have been disclosed previously. To demonstrate the modularity of the previous routes, three natural products (compounds 6, 13, 15) and four analogs (compounds 17-20) have been divergently prepared from a common building block featuring varied acyl chains at the C2, C3, and C8 positions. Biological tests revealed that all of the compounds prepared displayed promising activity profiles.
Additional supporting data may be found in the supplementary information of this article. Figure S1. CXCL5 staining of skin and epidermal equivalents after irradiation. Figure S2. mRNA and protein expression of CXCL5 in monocultured keratinocytes, fibroblasts, skin and epidermal equivalents under basal conditions. Appendix S1. Materials and Methods. Abstract: Experiments were conducted to develop a model to study the effect of oral and topical administration of the NK1 receptor antagonist aprepitant, on scratching behaviour in gerbils. The gerbil was selected due to its relevance for human NK1 receptor pharmacology. Intradermal injection of a specific NK1 receptor agonist GR73632 (100 nmol/100 µl) at the rostral back of gerbils produced scratching of the injection site. This could be attenuated by intradermal co-administration of a selective NK1 receptor antagonist aprepitant (30-100-300 nmol), demonstrating the role of dermal NK1 receptor in elicitation of scratching behaviour. Likewise, scratching was attenuated by oral (0.3-3-30 mg/kg) or topical application (0.01-0.1-1% w/v) of aprepitant and pharmacokinetic analysis of aprepitant levels in brain, blood and skin supported that efficacy of topically applied aprepitant was due to dermal rather than central target engagement. In conclusion, we showed that NK1 agonist-induced scratching in the gerbil can be reversed by systemic and topical administration of aprepitant. This test system may provide a useful model for the in vivo assessment of putative antipruritic agents.
Western blot analysis showed that all HDIs studied downregulated the anti-apoptotic protein cFLIP, but only VPA additionally affected the expression level of XIAP. Furthermore, in models of the intrinsic apoptosis pathway, i.e. in HepG2 cells treated with Melphalan and in primary hepatocytes irradiated with UV light, only VPA exhibited significant sensitisation.These findings extend the biochemical, pharmacological and toxicological basis for HDI therapy and provide a caveat for clinical use in patients with an accompanying critical inflammatory state in which the CD95 system might be pre-activated.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.